Antigen News and Research

RSS
Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Children with MIS-C have highly activated immune systems, study finds

Children with MIS-C have highly activated immune systems, study finds

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

New initiative aims to increase prostate cancer screening in African Americans men

New initiative aims to increase prostate cancer screening in African Americans men

New vaccination strategy could eliminate the bacteria that cause UTIs

New vaccination strategy could eliminate the bacteria that cause UTIs

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A backbone free energy study of SARS-CoV-2 variants of concern

A backbone free energy study of SARS-CoV-2 variants of concern

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location

COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location

FDA undertakes new action in its ongoing response effort to COVID-19 pandemic

FDA undertakes new action in its ongoing response effort to COVID-19 pandemic

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2

Pre-existing cross-reactive HCoV antibodies could protect against SARS-CoV-2